Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: Findings of a French survey

Clinical Infectious Diseases

Volumn 22, Issue 1, 1996, Pages 63-72

  Bédos, Jean Pierre ^a   Chevret, Sylvie ^b   Chastang, Claude ^b   Geslin, Pierre ^b   Régnier, Bernard ^b  

^a BICHAT HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; OXACILLIN; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; FEMALE; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; PARANASAL SINUS DISEASE; PRIORITY JOURNAL; RISK FACTOR; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0030046008     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.1.63     Document Type: Article

References (71)

1. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 1992;14:801-9.
2. Fine MJ, Orloff JJ, Arisumi D, et al. Prognosis of patients hospitalized with community-acquired pneumonia. Am J Med 1990;88(suppl 5N):1N-8N.
3. Hansman D, Bullen MM. A resistant pneumococcus [letter]. Lancet 1967;2:264-5.
4. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
5. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990;3:171-96.
6. Fenoll A, Martín Bourgon C, Muñóz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991;13:56-60.
7. Cybulska J, Jeljaszewicz J, Lund E, Munksgaard A. Prevalence of types of Diplococcus pneumoniae and their susceptibility to 30 antibiotics. Chemotherapy 1970;15:304-16.
8. Marton A. Pneumococcal antimicrobial resistance: the problem in Hungary. Clin Infect Dis 1992;15:106-11.
9. Marton A, Gulyas M, Munoz R, Tomasz A. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis 1991;163:542-8.
10. Millar M, Grover M, Osbourne F, Antoniou A. Control of antibiotic-resistant Streptococcus pneumoniae in Romania [letter]. Lancet 1991;338:323.
11. Geslin P, Frémaux A, Sissia G. Epidemiologie de la résistance de Streptococcus pneumoniae aux bêta-lactamines en France et dans le monde. In: Carbon C, Chastang C, Decazes JM, eds. Infections à pneumocoque de sensibilité diminuée aux bêta-lactamines. Paris: Springer-Verlag, 1993:55-72.
12. Burman LÅ, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1985;7:133-42.
13. Montgomery JM, Lehmann D, Smith T, et al. Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in highland children of Papua New Guinea. Rev Infect Dis 1990;12(suppl 8):S1006-16.
14. Geslin P, Frémaux A, Sissia G. Infections à pneumocoque: aspects épidémiologiques en 1992. Médecine et Maladies Infectieuses 1992;22(HS): 66-71.
15. Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ, the Pneumococcal Surveillance Working Group. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis 1991;163:1273-8.
16. Linares J, Pallares R, Alonso T, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992;15:99-105.
17. Baquero F, Martínez-Beltrán J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991;28(suppl C):31-8.
18. Muñoz R, Coffey TJ, Daniels M, et al. Intercontinental spread of a multiresistant clone of serotype 23 F Streptococcus pneumoniae. J Infect Dis 1991;164:302-6.
19. Radetsky MS, Istre GR, Johansen TL, et al. Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care centre. Lancet 1981;2:771-3.
20. Rauch AM, O'Ryan M, Van R, Pickering LK. Invasive disease due to multiply resistant Streptococcus pneumoniae in a Houston, Tex, day-care center. Am J Dis Child 1990;144:923-7.
21. Cohen R, De La Roque F, Boucherat M, Frémaux A, Sissia G, Geslin P. Flore rhino-pharyngée et résistance du pneumocoque. In: Carbon C, Chastang C, Decazes JM, eds. Infections à pneumocoque de sensibilité diminuée aux bêta-lactamines. Paris: Springer-Verlag, 1993:73-80.
22. Henderson FW, Gilligan PH, Wait K, Goff DA. Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis 1988;157:256-63.
23. Doyle MG, Morrow AL, Van R, Pickering LK. Intermediate resistance of Streptococcus pneumoniae to penicillin in children in day-care centers. Pediatr Infect Dis J 1992;11:831-5.
24. Hendley JO, Sande MA, Stewart PM, Gwaltney JM Jr. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis 1975;132:55-61.
25. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993;168: 158-63.
26. Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP. Pneumococcal bacteremia in Charleston County, South Carolina: a decade later. Arch Intern Med 1990;150:1401-5.
27. Cowan MJ, Ammann AJ, Wara DW, et al. Pneumococcal polysaccharide immunization in infants and children. Pediatrics 1978;62:721-7.
28. Douglas RM, Paton JC, Duncan SJ, Hansman DJ. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 1983;148:131-7.
29. Gray BM, Converse GM III, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980;142:923-33.
30. Klein JO. The epidemiology of pneumococcal disease in infants and children. Rev Infect Dis 1981;3:246-53.
31. Verghese A, Berk SL. Bacterial pneumonia in the elderly. Medicine (Baltimore) 1983;62:271-85.
32. Geslin P, Buu-Hoi A, Frémaux A, Acar JF. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clin Infect Dis 1992;15:95-8.
33. Boucot I, Poyart C, Bingen E, Lambert-Zechovsky N, Berche P. Activité des antibiotiques sur les pneumocoques de sensibilité anormale à la pénicilline G isolés d'otites moyennes aiguës communautaires. In: Carbon C, Chastang C, Decazes JM, eds. Infections à pneumocoque de sensibilité diminuée aux bêta-lactamines. Paris: Springer-Verlag, 1993:89-98.
34. Bédos JP, Rolin O, Bouanchaud DH, Pocidalo JJ. Relation entre virulence et résistance aux antibiotiques des pneumocoques. Apport des donnée expérimentales sur un modèle animal. Pathol Biol (Paris) 1991;39: 984-90.
35. Briles DE, Crain MJ, Gray BM, Forman C, Yother J. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect Immun 1992;60:111-6.
36. Kaufhold A, Lütticken R, Henrichsen J. Capsular types and antibiotic susceptibility of Streptococcus pneumoniae isolated from patients with systemic infections in West Germany [letter]. Eur J Clin Microbiol 1987;6:696-7.
37. Nielsen SV, Henrichsen J. Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987. Clin Infect Dis 1992;15:794-8.
38. Jetté LP, Lamothe F, Pneumococcus Study Group. Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol 1989;27:1-5.
39. Klugman KP, Koornhof HJ. Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986. J Infect Dis 1988;158:956-64.
40. Klugman KP, Koornhof HJ, Wasas A, Storey K, Gilbertson I. Carriage of penicillin resistant pneumococci. Arch Dis Child 1986;61:377-81.
41. Koornhof HJ, Wasas A, Klugman K. Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective. Clin Infect Dis 1992;15:84-94.
42. Oppenheim B, Koornhof HJ, Austrian R. Antibiotic-resistant pneumococcal disease in children at Baragwanath Hospital, Johannesburg. Pediatr Infect Dis 1986;5:520-4.
43. Casal J. Antimicrobial susceptibility of Streptococcus pneumoniae: serotype distribution of penicillin-resistant strains in Spain. Antimicrob Agents Chemother 1982;22:222-5.
44. Andersson B, Eriksson B, Falsen E, et al. Adhesion of Streptococcus pneumoniae to human pharyngeal epithelial cells in vitro: differences in adhesive capacity among strains isolated from subjects with otitis media, septicemia, or meningitis or from healthy carriers. Infect Immun 1981;32:311-7.
45. Wikström MB, Dahlén G, Kaijser B, Nygren H. Degradation of human immunoglobulins by proteases from Streptococcus pneumoniae obtained from various human sources. Infect Immun 1984;44:33-7.
46. Sell SH, Wright PF, Vaughn WK, Thompson J, Schiffman G. Clinical studies of pneumococcal vaccines in infants: I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. Rev Infect Dis 1981;3(suppl):S97-107.
47. Austrian R. Epidemiology of pneumococcal capsular types causing pediatric infections. Pediatr Infect Dis J 1989;8(suppl):S21-2.
48. Siegel JD, Poziviak CS, Michaels RH. Serotypically defined pneumococcal infections in children. J Pediatr 1978;93:249-50.
49. Pedersen FK, Henrichsen J. Pneumococcal meningitis and bacteraemia in Danish children 1969-1978: serotypes, incidence and outcome. Acta Pathol Microbiol Immunol Scand 1983;91B:129-34.
50. Giebink GS, Berzins IK, Marker SC, Schiffman G. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect Immun 1980;30:445-50.
51. Henderson FW, Collier AM, Sanyal MA, et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 1982;306:1377-83.
52. Loda FA, Collier AM, Glezen WP, Strangert K, Clyde WA Jr, Denny FW. Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J Pediatr 1975;87:1087-93.
53. Eskola J, Takala AK, Kela E, Pekkanen E, Kalliokoski R, Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 1992;268:3323-7.
54. Gray BM, Dillon HC. Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis 1986;5:201-7.
55. Gordon DL, Johnson GM, Hostetter MK. Ligand-receptor interactions in the phagocytosis of virulent Streptococcus pneumoniae by polymorphonuclear leukocytes. J Infect Dis 1986;154:619-26.
56. Hostetter MK. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J Infect Dis 1986;153:682-93.
57. Pallares R, Gudiol F, Liñares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987;317:18-22.
58. Léophonte P, Mularczyk M, Rouquet RM, Geslin P. Résultats d'une enquête nationale sur les pneumonies à pneumocoque hospitalisées (210 cas). In: Carbon C, Chastang C, Decazes JM, eds. Infections à pneumocoque de sensibilité diminuée aux bëta-lactamines. Paris: Springer-Verlag, 1993:99-108.
59. Carratala J, Gudiol F, Pallarès R, et al. Nosocomial penicillin-resistant pneumococcal pneumonia: analysis of risk factors outcome [abstract no. 1019]. In: Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy (Atlanta). Washington, DC: American Society for Microbiology, 1990.
60. Redd SC, Rutherford GW III, Sande MA, et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990;162:1012-7.
61. Polsky B, Gold JWM, Whimbey E, et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986;104:38-41.
62. Selwyn PA, Feingold AR, Hartel D, et al. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS 1988;2:267-72.
63. Simberkoff MS, El Sadr W, Schiffman G, Rahal JJ Jr. Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with a report of a pneumococcal vaccine failure. Am Rev Respir Dis 1984;130:1174-6.
64. Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection: epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992;117:314-24.
65. Nava JM, Bella F, Garau J, et al. Streptococcus pneumoniae invasive disease: factors predictive of infection by penicillin resistant strains [abstract no. 1032]. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1991.
66. García-Leoni EM, Cercenado E, Rodeño P, Bernaldo de Quirós JCL, Martínez-Hernández D, Bouza E. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis 1992;14:427-35.
67. Müller F, Frøland SS, Hvatum M, Radl J, Brandtzaeg P. Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol 1991;83:203-9.
68. Sestini P, Nencioni L, Villa L, Boraschi D, Tagliabue A. IgA-driven antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes. Am Rev Respir Dis 1988;137:138-43.
69. Müller F, Frøland SS, Brandtzaeg P. Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV). Clin Exp Immunol 1989;78:153-8.
70. Tausk FA, McCutchan JA, Spechko P, Schreiber RD, Gigli I. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J Clin Invest 1986;78:977-82.
71. Bender BS, Bohnsack JF, Sourlis SH, Frank MM, Quinn TC. Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome. J Clin Invest 1987;79:715-20.